Clinical Trial

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Recruiting
View on ClinicalTrials.gov →
Summary
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial
Trial Details
NCT Number NCT07754175
Lead Sponsor Kang Stem Biotech Co., Ltd.
Conditions Knee Osteoarthritis
Enrollment 36 participants
Start Date 2026-07-20
Primary Completion 2031-12-31 (estimated)
Study Completion 2032-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-10